Literature DB >> 8097297

Co-variation of free amino acids in human epileptogenic cortex.

A Hamberger1, K Haglid, B Nyström, H Silfvenius.   

Abstract

The concentration of free amino acids was measured in 41 surgically removed samples of human epileptogenic brain and in 7 specimens of non-epileptic brain tissue, removed during surgery for meningiomas, etc. The material was subdivided according to the neuropathological diagnosis: mild cortical dysplasia (MCD), gliosis astrocytoma infiltration and a histologically heterogeneous group. The non-tumoral epileptogenic samples had five times higher than normal concentration of ethanolamine and 50% elevated concentration of glycine. The concentration of other neurotransmitter amino acids did not differ markedly between epileptogenic and non-epileptic samples. The concentration of neurotransmitter amino acids showed a strong correlation with the enzyme neuron specific enolase (NSE) and were low in most samples with astrocytoma infiltration. On the other hand, tyrosine and leucine had higher concentrations in samples with lower NSE concentration. Factor analysis of the amino acids revealed four groups of covarying compounds in the brain samples, first, a neurotransmitter group, including aspartate, glutamate, GABA and phosphoethanolamine. Another group contained ethanolamine, glutamine, glycine and taurine. Factor analysis on corresponding extracellular amino acids showed two groups, the first being a "neurotransmitter" group, containing serine, taurine phosphoethanolamine and ethanolamine in addition to aspartate and glutamate. The other group consisted of asparagine, glycine, alanine, tyrosine, valine, phenylalanine, isoleucine and leucine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097297     DOI: 10.1007/bf00967256

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  14 in total

1.  Excitatory amino acids are elevated in human epileptic cerebral cortex.

Authors:  A Sherwin; Y Robitaille; F Quesney; A Olivier; J Villemure; R Leblanc; W Feindel; E Andermann; J Gotman; F Andermann
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

2.  The effect of an N-methyl-D-aspartate lesion in the hippocampus on glial and neuronal marker proteins.

Authors:  S Wang; G J Lees; L E Rosengren; J E Karlsson; T Stigbrand; A Hamberger; K G Haglid
Journal:  Brain Res       Date:  1991-02-15       Impact factor: 3.252

3.  The synthesis of choline and ethanolamine phosphoglycerides in neuronal and glial cells of rabbit in vitro.

Authors:  L Binaglia; G Goracci; G Porcellati; R Roberti; H Woelk
Journal:  J Neurochem       Date:  1973-11       Impact factor: 5.372

4.  Amino acid content of epileptogenic human brain: focal versus surrounding regions.

Authors:  N M Van Gelder; A L Sherwin; T Rasmussen
Journal:  Brain Res       Date:  1972-05-26       Impact factor: 3.252

5.  Phosphoethanolamine transiently enhances excitability of rat hippocampal neurons in vitro.

Authors:  M Zeise; A Lehmann
Journal:  J Comp Physiol A       Date:  1987-08       Impact factor: 1.836

6.  A multicentre study of vigabatrin for drug-resistant epilepsy.

Authors:  T R Browne; R H Mattson; J K Penry; D B Smith; D M Treiman; B J Wilder; E Ben-Menachem; R M Miketta; K M Sherry; G K Szabo
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 7.  Amino acid neurotransmitters and new approaches to anticonvulsant drug action.

Authors:  B Meldrum
Journal:  Epilepsia       Date:  1984       Impact factor: 5.864

8.  Amino acids in the neuronal microenvironment of focal human epileptic lesions.

Authors:  A Hamberger; B Nyström; S Larsson; H Silfvenius; C Nordborg
Journal:  Epilepsy Res       Date:  1991 May-Jun       Impact factor: 3.045

9.  Amino acid abnormalities in epileptogenic foci.

Authors:  T L Perry; S Hansen
Journal:  Neurology       Date:  1981-07       Impact factor: 9.910

Review 10.  Amino acid and catecholamine markers of metabolic abnormalities in human focal epilepsy.

Authors:  A L Sherwin; N M van Gelder
Journal:  Adv Neurol       Date:  1986
View more
  4 in total

1.  Disturbances of amino acids from temporal lobe synaptosomes in human complex partial epilepsy.

Authors:  D M Labiner; C C Yan; M E Weinand; R J Huxtable
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

Review 2.  Metabolic parameters of epilepsy: adjuncts to established antiepileptic drug therapy.

Authors:  Nico M van Gelder; Allan L Sherwin
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

Review 3.  Vagus nerve stimulation for epilepsy and depression.

Authors:  Andrew H Milby; Casey H Halpern; Gordon H Baltuch
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

Review 4.  Vagus nerve stimulation in the treatment of refractory epilepsy.

Authors:  Andrew H Milby; Casey H Halpern; Gordon H Baltuch
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.